Literature DB >> 25242875

Increased Protein Tyrosine Phosphorylation in Apoptotic Neural Cell Death Due to Microtubule Perturbations.

Brett A Chromy1, Mary P Lambert1, William L Klein1.   

Abstract

The microtubule-perturbing drugs colchicine and taxol have been found to induce apoptosis in a CNS neuronal cell line. Apoptosis in drug-treated rat B103 neuroblastoma cells was evident in characteristic morphological changes, internucleosomal DNA fragmentation, and loss of nuclear content. Since colchicine and taxol have opposite actions on microtubule integrity, disruption of the active turnover of the microtubule network appears to be a crucial step for apoptosis to occur. It has been suggested that the basis for apoptosis by these drugs derives from their known block of the cell cycle at G2/M, but this does not appear the sole reason as both colchicine and taxol were able to evoke high levels of apoptosis in cells differentiated by Bt2cAMP or serum withdrawal. Further tests of cellular consequences of microtubule perturbation revealed a specific impact on signal transduction involving protein tyrosine phosphorylation. Immunoprecipitation with antibodies against tyrosine phosphorylated proteins showed a striking increase in the phosphorylation of a Triton-insoluble ~90 kDa protein, roughly concurrent with the onset of internucleosomal DNA fragmentation. Cycloheximide and genistein significantly reduced cell death and blocked appearance of the ~90 kDa tyrosine phosphorylated protein. Data suggest the hypothesis that signal transduction leading to apoptosis can be triggered by anomalous microtubule turnover and that the mechanism involves tyrosine phosphorylation of a ~90 kDa Triton-resistant protein.

Entities:  

Keywords:  B103; Cell cycle; colchicine; neuron; taxol

Year:  2000        PMID: 25242875      PMCID: PMC4167016          DOI: 10.1007/BF03033343

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  52 in total

Review 1.  Coupling cell division and cell death to microtubule dynamics.

Authors:  P K Sorger; M Dobles; R Tournebize; A A Hyman
Journal:  Curr Opin Cell Biol       Date:  1997-12       Impact factor: 8.382

Review 2.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

3.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau.

Authors:  D Panda; B L Goode; S C Feinstein; L Wilson
Journal:  Biochemistry       Date:  1995-09-05       Impact factor: 3.162

4.  Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors.

Authors:  Y Muragaki; T T Chou; D R Kaplan; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

5.  Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages.

Authors:  C L Manthey; M E Brandes; P Y Perera; S N Vogel
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

6.  Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.

Authors:  W B Pope; M P Lambert; B Leypold; R Seupaul; L Sletten; G Krafft; W L Klein
Journal:  Exp Neurol       Date:  1994-04       Impact factor: 5.330

7.  The protein tyrosine kinase, fyn, in Alzheimer's disease pathology.

Authors:  S K Shirazi; J G Wood
Journal:  Neuroreport       Date:  1993-04       Impact factor: 1.837

8.  Activation of p34cdc2 coincident with taxol-induced apoptosis.

Authors:  K L Donaldson; G L Goolsby; P A Kiener; A F Wahl
Journal:  Cell Growth Differ       Date:  1994-10

9.  Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol).

Authors:  J Liebmann; J A Cook; D Teague; J Fisher; J B Mitchell
Journal:  Anticancer Drugs       Date:  1994-06       Impact factor: 2.248

Review 10.  Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators.

Authors:  B W Stewart
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.